Fady Baselious

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Molecular Dynamics Simulations

Top Venues

Drug development research

Archiv der Pharmazie

International journal of molecular sciences

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Fady Baselious, Sebastian Hilscher, Sven Hagemann, Sunita Tripathee, Dina Robaa, Cyril Barinka, Stefan Hüttelmaier, Mike Schutkowski, Wolfgang Sippl
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity. Archiv der Pharmazie (2024)
Dana M Odeh, Heba Abdelrasheed Allam, Fady Baselious, Walaa R Mahmoud, Mohanad M Odeh, Hany S Ibrahim, Hatem A Abdel-Aziz, Eman R Mohammed
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors. Drug development research 85 (3) (2024)
Dana M Odeh, Heba Abdelrasheed Allam, Fady Baselious, Walaa R Mahmoud, Mohanad M Odeh, Hany S Ibrahim, Hatem A Abdel-Aziz, Eman R Mohammed
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors. Drug development research 85 (3) (2024)
Fady Baselious, Sebastian Hilscher, Dina Robaa, Cyril Barinka, Mike Schutkowski, Wolfgang Sippl
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor. International journal of molecular sciences 25 (2) (2024)
Sebastian Mielniczuk, Katharina Hoff, Fady Baselious, Yunqi Li, Jörg Haupenthal, Andreas M Kany, Maria Riedner, Holger Rohde, Katharina Rox, Anna Katharina Herta Hirsch, Isabelle Krimm, Wolfgang Sippl, Ralph Holl
Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity. Journal of medicinal chemistry (2024)
Fady Baselious, Sebastian Hilscher, Dina Robaa, Cyril Barinka, Mike Schutkowski, Wolfgang Sippl
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor. International journal of molecular sciences 25 (2) (2024)
Francesco Berluti, Fady Baselious, Sven Hagemann, Sebastian Hilscher, Matthias Schmidt, Stefan Hüttelmaier, Mike Schutkowski, Wolfgang Sippl, Hany S Ibrahim
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells. Archiv der Pharmazie (2024)